Stockholder's Equity (Details) (USD $)	0 Months Ended							3 Months Ended	6 Months Ended	12 Months Ended
	Jul. 14, 2014	Jun. 18, 2014	Jun. 13, 2014	Jun. 06, 2014 item	May 21, 2014 item	May 06, 2014	Apr. 29, 2014	Jul. 10, 2014	Jun. 30, 2014	Dec. 31, 2013
Stockholder's Equity.
Outstanding shares, Beginning									5,813,785	890,837
Conversion of Series E Preferred to common stock										1,575,000
Shares issued for acquisition of Canterbury and Hygeia										1,150,116
Conversion of warrants to common stock										1,023,264
Conversion of debt to common stock									552,738	576,331
Issuance of shares for advisory agreements										243,250
Issuance of shares for assumption of liabilities									150,000	200,000
Issuance of common stock for cash										142,501
Other.										12,486
Shares issued in private placement									8,845,685
Shares issued for acquisition of Paloma									2,500,000
Shares issued to creditors in settlement of debt									408,317
Shares issued for acquisition of VasculoMedics									220,000
Shares surrendered by ASC									(99,332)
Outstanding shares, Ending									18,391,193	5,813,785
Shares issued									12,676,740
Shares issued for acquisition of Paloma and VasculoMedics									2,720,000
Shares issued to creditors in settlement of outstanding debt					164,392				408,317
Aggregate number of shares of common stock issued in private placement									8,845,685
Shares issued to various institutional and individual accredited investors			1,778,750		872,310	3,418,125	2,776,500	50,000
Term of warrants issued to various institutional and individual accredited investors			4 years		4 years	4 years	4 years	4 years
Number of shares of common stock to be purchased by various institutional and individual accredited investors			533,625		254,193	1,025,438	832,950	15,000
Number of shares of common stock consisted in unit			1		1	1	1	1
Number of warrants consisted in unit			0.3		0.3	0.3	0.3	0.3
Strike price (in dollars per share)			$ 4.00		$ 4.00	$ 4.00	$ 4.00	$ 4.00
Exercise price of warrants issued to various institutional and individual accredited investors			$ 4.80		$ 4.80	$ 4.80	$ 4.80	$ 4.80
Number of shares of common stock to be purchased by placement agent			177,875		87,231	341,813	277,650	5,000
Proceeds from private placement								$ 35,600,000
Net proceeds from private placement after payment fees								31,300,000
Placement agent fees paid								3,600,000
Estimated offering expenses paid								200,000
Certain accounts payable paid								500,000
Number of shares of common stock for which registration statement is filed for offering and resale of common stock	11,633,885
Shares issued to creditors pursuant to conversion of outstanding debt					259,236
Principal amount of promissory note converted				1,050,000	500,000
Number of creditors to whom shares are issued in settlement of outstanding debt					4
Shares issued to former Chief Financial Officer in settlement of outstanding debt					59,250
Loss on settlement of debt				$ 1,829,561	$ 32,608
Shares issued to chairman in settlement of outstanding debt				552,738
Number of shares of common stock issued to Chairman in settlement of outstanding debt				355,699
Exercise price of warrants issued to chairman in settlement of outstanding debt				$ 2.00
Number of convertible promissory notes issued				4
Shares issued to law firm pursuant to conversion of outstanding debt		53,457
Number of shares of common stock to be purchased by law firm		16,037